These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7525116)

  • 1. Variance function as basis for assessment of test performance: methodological studies with two assays of prostate-specific antigen.
    Hänseler E; Keller B; Keller H
    Clin Chem; 1994 Nov; 40(11 Pt 1):2046-52. PubMed ID: 7525116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SR1 assays of alpha-fetoprotein, carcinoembryonic antigen, and prostate-specific antigen compared with corresponding established commercial assays.
    Jolley NL; Bacarese-Hamilton T
    Clin Chem; 1994 Jun; 40(6):895-9. PubMed ID: 7522136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new look at the limits of detection (LD), quantification (LQ) and power of definition (PD).
    Gautschi K; Keller B; Keller H; Pei P; Vonderschmitt DJ
    Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):433-40. PubMed ID: 8399783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new mathematical procedure for the assessment of test performance of PSA assays.
    Hänseler E; Keller H
    Scand J Clin Lab Invest Suppl; 1995; 221():52-6. PubMed ID: 7544485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical performance goals for measuring prostate-specific antigen.
    Fritsche HA; Babaian RJ
    Clin Chem; 1993 Jul; 39(7):1525-7; discussion 1527-9. PubMed ID: 7687205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.
    Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A
    Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abbott IMx evaluated for assay of prostate-specific antigen in serum.
    Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR
    Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay.
    Klee GG; Dodge LA; Zincke H; Oesterling JE
    J Urol; 1994 Jan; 151(1):94-8. PubMed ID: 7504749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.
    Vessella RL; Noteboom J; Lange PH
    Clin Chem; 1992 Oct; 38(10):2044-54. PubMed ID: 1382897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The analytical and clinical performance of the new Boehringer Mannheim Enzymun-Test PSA assay for prostate-specific antigen.
    Blijenberg BG; Eman I; Boevé ER; Mössner E; Uhl W
    Eur J Clin Chem Clin Biochem; 1995 Jun; 33(6):383-92. PubMed ID: 7578619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.
    Manseck A; Pilarsky C; Froschermaier S; Menschikowski M; Wirth MP
    Urol Int; 1998; 60(1):25-7. PubMed ID: 9519417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays.
    Zhou AM; Tewari PC; Bluestein BI; Caldwell GW; Larsen FL
    Clin Chem; 1993 Dec; 39(12):2483-91. PubMed ID: 7504592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three commercial PSA assays: results of restandardization of the Ciba Corning method.
    Brawer MK; Bankson DD; Haver VM; Petteway JC
    Prostate; 1997 Mar; 30(4):269-73. PubMed ID: 9111605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.
    van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO
    Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the COBAS CORE Immunoassay for measuring prostate-specific antigen (PSA)--multi-centre study results. The PSA Study Group.
    Schambeck CM
    Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):541-7. PubMed ID: 8547440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a highly sensitive immunochemiluminometric assay for prostate-specific antigen.
    Klee GG; Preissner CM; Oesterling JE
    Urology; 1994 Jul; 44(1):76-82. PubMed ID: 7518985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx.
    Oesterling JE; Moyad MA; Wright GL; Beck GR
    Urology; 1995 Oct; 46(4):524-32. PubMed ID: 7571222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four automated prostate-specific antigen assays for detection of recurrence after radical prostatectomy.
    Sanders H; Graham SD
    Urology; 1997 Jun; 49(6):894-7. PubMed ID: 9187697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology.
    Roehrborn CG; Gregory A; McConnell JD; Sagalowsky AI; Wians FH
    Urology; 1996 Dec; 48(6A Suppl):23-32. PubMed ID: 8973696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Ciba Corning ACS:180 automated immunoassay system.
    Mora-Brugués J; Gascón-Roche N; Rodríguez-Espinosa J; Cortés-Rius M; González-Sastre F
    Clin Chem; 1994 Mar; 40(3):407-10. PubMed ID: 7510590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.